Opioid overdose

An opioid overdose occurs when circulating opioids suppress the brainstem's respiratory drive beyond the body's ability to compensate — breathing slows to a dangerous rate, becomes irregular, or stops.

Opioids achieve this by binding to mu-opioid receptors in brainstem structures that set the rhythm and depth of each breath. As opioid concentration rises — from a high dose, reduced tolerance, or a substance more potent than expected — that suppression deepens until breathing can no longer sustain adequate oxygen delivery.

The state is often quiet. There is typically no seizure or cry out. A person moves from sedation into loss of consciousness without visible distress, which makes bystander recognition the primary survival variable.

How it is done

Recognition depends on a cluster of signs rather than any single one. The most reliable is breathing: very slow, very shallow, or absent. Pinpoint pupils and failure to respond to a loud voice or firm pressure on the sternum support the picture. Cyanosis — the blue-grey discolouration of lips and fingertips — indicates that oxygen deprivation is already advanced.

Response begins with calling emergency services. If naloxone is available, it is administered into muscle or nostril and can reverse respiratory depression by displacing opioids from their receptors within minutes. If breathing is absent, rescue breathing supports the person while naloxone takes effect. Once breathing returns, placing the person in the recovery position reduces the risk of airway obstruction.

Because naloxone's duration of action is shorter than that of many opioids, close monitoring continues after revival. A return of overdose — re-narcotization — is a documented risk, particularly with long-acting or fentanyl-class compounds.

When it matters

Opioid overdose is a medical emergency from the moment breathing becomes inadequate. The window between onset and irreversible harm from hypoxia can be short, and the quiet presentation means time passes before a bystander recognises what is happening.

Tolerance loss during a period of abstinence — following incarceration, hospitalisation, or a recovery attempt — is among the most consistent risk factors for a fatal outcome. A quantity that was tolerated before the break may no longer be tolerated after it.

What it cannot tell you

Revival after naloxone confirms opioid involvement. It does not confirm that opioids were the only substance present.

Polydrug overdose is common. Alcohol, benzodiazepines, and other central nervous system depressants compound respiratory depression through mechanisms naloxone cannot reach. A person who stabilises after naloxone may still carry a co-present depressant that continues to act.

The absence of the classic signs does not rule out overdose. Pupil size can be unreliable depending on other substances or individual baseline conditions. Some synthetic opioids produce presentations that diverge from the familiar picture — heart rate, for instance, may be normal or elevated rather than depressed.

A reassuring response to the first dose of naloxone is not an all-clear. High-potency compounds may displace the antidote before its effect wanes, and re-narcotization can occur after a period of apparent stability. The endpoint of a successful intervention is sustained, adequate breathing — not a single moment of recovery.